Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives
08/03/2018
NIH-funded study observes no significant reduction of infection rates at age 6 months.
NIH-funded study observes no significant reduction of infection rates at age 6 months.